AXL and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, the upregulation of AXL has been associated with a poor clinical prognosis and increased cell proliferation (12, 13), while stable knockdown of AXL resulted in a significant reduction in cell viability and anchorage-independent growth in pancreatic cancer cells (50).